{"id":"W4410267430","doi":"10.1016/j.bneo.2025.100115","title":"Tagraxofusp, a CD123-targeted therapy, for chronic myelomonocytic leukemia: final results of a phase 1/2 study","year":2025,"lang":"en","type":"article","venue":"Blood Neoplasia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Menarini Group","keywords":"Chronic myelomonocytic leukemia; Medicine; Interleukin-3 receptor; Leukemia; Oncology; Phase (matter); Internal medicine; Cancer research; Chemistry; Myelodysplastic syndromes; Bone marrow","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007733282,0.0003773975,0.0008739981,0.0005618755,0.0001567004,0.00003180595,0.0004075074,0.0002387038,0.00006144561],"category_scores_gemma":[0.000739808,0.0003210527,0.0002826751,0.001076816,0.0001699377,0.0000893691,0.0001407925,0.0005575701,0.00002212599],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000840531,"about_ca_system_score_gemma":0.005006494,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002902882,"about_ca_topic_score_gemma":0.0001227354,"domain_scores_codex":[0.997008,0.0001426952,0.0008655178,0.0007459664,0.000514521,0.0007233212],"domain_scores_gemma":[0.9976082,0.0005955675,0.0002174265,0.0009935068,0.0003828174,0.0002024956],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1202985,0.03215357,0.01448437,0.003104382,0.01095095,0.001785713,0.00682782,0.0001370239,0.3939376,0.0009938093,0.1166594,0.2986669],"study_design_scores_gemma":[0.5324147,0.05015536,0.02564228,0.0009023827,0.002694783,0.0002814342,0.002308596,0.008434562,0.332676,0.000431272,0.04311297,0.000945692],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9888743,0.002028812,0.0002803082,0.0009607919,0.0001694636,0.004900591,0.0001579842,0.000139906,0.002487892],"genre_scores_gemma":[0.991277,0.0002313677,0.001050922,0.0002358908,0.0002465116,0.0005765607,0.0001308842,0.00005628433,0.006194596],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4121161,"threshold_uncertainty_score":0.9999242,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03274721435044482,"score_gpt":0.349430216785658,"score_spread":0.3166830024352132,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}